|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:1-8
© 1999 Mosby, Inc.
CARDIOTHORACIC TRANSPLANTATION |
From the Thoracic Surgery Research Laboratory, Division of Thoracic Surgery, The Toronto Hospital Research Institute,a Medical Research Council Group in Lung Development, Department of Paediatrics, The Hospital for Sick Children,b and Division of Respiratory Medicine, Mount Sinai Hospital,c University of Toronto, Toronto, Ontario, Canada.
This work was supported by a grant from the National Sanitarium Association of Canada. Dr Liu is a scholar of the Medical Research Council of Canada. Dr Boehler is a recipient of grants from the Swiss National Scientific Foundation and the Swiss Respiratory Society.
Read at the Seventy-eighth Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 3-6, 1998.
Received for publication April 6, 1998. Revisions requested June 23, 1998. Revisions received July 24, 1998. Accepted for publication Sept 8, 1998. Address for reprints: Shaf Keshavjee, MD, Division of Thoracic Surgery, The Toronto Hospital, EN-10-224, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4.J Thorac Cardiovasc Surg 1999;117:1-7
Objectives: Adenovirus-mediated gene therapy has been proposed as a potential treatment modality in lung transplantation. However, to date its utility has been limited by an inflammatory host immune response that not only limits the amount and duration of transgene expression but also obviates successful retransfection. Having previously shown that by administering triple-immunosuppression, as is routine in lung transplantation, we could increase and prolong transgene expression after initial transfection, we hypothesized that transgene expression after retransfection could also be increased and prolonged.
Methods: Lewis rats underwent intratracheal adenovirus-mediated transfection with the ß-galactosidase gene and were randomized to either the immunosuppression group, receiving daily cyclosporine (INN: ciclosporin), azathioprine, and methylprednisolone, or the control group (no immunosuppression). Five weeks later, rats were similarly retransfected and transgene expression and post-transfection inflammation were evaluated 1, 7, and 14 days after retransfection.
Results: After retransfection, immunosuppressed rats had significantly higher levels of transgene expression (P < .001), whereas control rats had virtually no detectable levels. On histologic sections of the lungs, immunosuppressed rats had overall lesser grades of post-transfection inflammation.
Conclusions: Transplant immunosuppression attenuates the severe immune response to gene transfer and permits increased, prolonged, and repeated transfection. Retransfection is now achievable in the immunosuppressed lung transplant setting to allow for chronic, repeated administration of gene therapy.
This article has been cited by other articles:
![]() |
K. Ohmori, S.-i. Takeda, S. Miyoshi, M. Minami, S. Nakane, M. Ohta, Y. Sawa, and H. Matsuda Application of HVJ-liposome mediated gene transfer in lung transplantation--distribution and transfection efficiency in the lung Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 768 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suda, T. Tagawa, S. A. Kanaan, B. D. Kozower, N. Daddi, T. Mohanakumar, and G. A. Patterson Adenovirus encoding soluble tumor necrosis factor {alpha} receptor immunoglobulin prolongs gene expression of a cotransfected reporter gene in rat lung J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1155 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fischer, M. de Perrot, M. Liu, A. A. MacLean, J. A. Cardella, Y. Imai, M. Suga, and S. Keshavjee Interleukin 10 gene transfection of donor lungs ameliorates posttransplant cell death by a switch from cellular necrosis to apoptosis J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1174 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sadowski, B. Kapelak, K. Bartus, P. Podolec, P. Rudzinski, T. Myrdko, K. Wierzbicki, and A. Dziatkowiak Reoperation after fresh homograft replacement: 23 years' experience with 655 patients Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 996 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, S. Fischer, M. Liu, Y. Imai, S. Martins, S. Sakiyama, T. Tabata, X.-H. Bai, T. K. Waddell, B. L. Davidson, et al. Impact of Human Interleukin-10 on Vector-Induced Inflammation and Early Graft Function in Rat Lung Transplantation Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 616 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suga, R. Gladdy, Z. Xing, S. H. Keshavjee, and M. Liu Transplant immunosuppression enhances efficiency of adenoviral-mediated gene retransfection: inhibition of interferon-{gamma} and immunoglobin G Ann. Thorac. Surg., April 1, 2002; 73(4): 1092 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Smythe Gene therapy for thoracic disease: practice, promise, and pragmatism Ann. Thorac. Surg., March 1, 2002; 73(3): 704 - 706. [Full Text] [PDF] |
||||
![]() |
U. Stammberger, A. N. Uduehi, B. Kubisa, T. Roth, and R. A. Schmid Non-viral gene delivery to atelectatic and ventilated lungs Ann. Thorac. Surg., February 1, 2002; 73(2): 432 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. LIU, M. SUGA, A. A. MACLEAN, J. A. ST. GEORGE, D. W. SOUZA, and S. KESHAVJEE Soluble Transforming Growth Factor-beta Type III Receptor Gene Transfection Inhibits Fibrous Airway Obliteration in a Rat Model of Bronchiolitis Obliterans Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 419 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Shen, M. C. Lai, J. Beilby, N. L. Barnett, J. Liu, I. J. Constable, and P. E. Rakoczy Combined Effect of Cyclosporine and Sirolimus on Improving the Longevity of Recombinant Adenovirus-Mediated Transgene Expression in the Retina Arch Ophthalmol, July 1, 2001; 119(7): 1033 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lanuti, S. Rudginsky, S. D. Force, E. S. Lambright, W. M. Siders, M. Y. Chang, K. M. Amin, L. R. Kaiser, R. K. Scheule, and S. M. Albelda Cationic Lipid:Bacterial DNA Complexes Elicit Adaptive Cellular Immunity in Murine Intraperitoneal Tumor Models Cancer Res., June 1, 2000; 60(11): 2955 - 2963. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |